Previous 10 | Next 10 |
SAN DIEGO and PENNINGTON, N.J. , Sept. 6, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O'Connor , President and Chief Executive Officer of OncoSec, wi...
The following have filed for mixed shelf offerings: More news on: Intellia Therapeutics, Inc., OncoSec Medical Incorporated, Civeo Corporation, Healthcare stocks news, Energy stocks news, Read more ...
Genmab A/S (NASDAQ: GMAB ) initiated with Overweight rating and $30 (58% upside) price target at Morgan Stanley. Initiated with Outperform rating and $23 price target at RBC. Shares up 1% premarket. More news on: Genmab A/S, Fulcrum Therapeutics, Inc., Mirum Pharmaceuticals, In...
SAN DIEGO and PENNINGTON, N.J. , July 29, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of all...
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
SAN DIEGO and PENNINGTON, N.J , July 16, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today published a Letter to Shareholders from President and Chief Executive Officer, Daniel J. O...
OncoSec Medical ( ONCS ) announced that it had licensed CAR-T cell therapy for Triple-negative breast cancer (TNBC) and other solid tumors. The goal is to break through with the use of CAR-T therapies beyond liquid tumors. The latest license has a few advantages that OncoSec could exploi...
Dova Pharmaceuticals (NASDAQ: DOVA ) +32% as FDA OKs Dova's Doptelet for low blood platelets in ITP patients. More news on: Dova Pharmaceuticals, Inc., Atossa Genetics Inc., Zogenix, Inc., Stocks on the move, Read more ...
SAN DIEGO and PENNINGTON, N.J. , June 27, 2019 /PRNewswire/ -- OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced that it has entered into a collaboration with Dana-Farber Cancer Institute, a wo...
News, Short Squeeze, Breakout and More Instantly...
OncoSec Medical Incorporated Company Name:
ONCS Stock Symbol:
NASDAQ Market:
2023-06-25 06:00:00 ET 3 Tips for Investing in Penny Stocks in a Highly Volatile Market In the thrilling world of finance, penny stocks hold a unique place, providing investors with an affordable entry point and the potential for significant returns. As securities trading under $5 p...
2023-06-24 06:00:00 ET 3 Ways That Global Events Affect the Price of Penny Stocks The ever-changing global economic landscape inevitably impacts the financial markets, and penny stocks , defined as securities trading below $5 per share, are no exception. Particularly in 2023, these ...